It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GIKLY’s FA Score shows that 1 FA rating(s) are green whileOPHLY’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GIKLY’s TA Score shows that 6 TA indicator(s) are bullish while OPHLY’s TA Score has 4 bullish TA indicator(s).
GIKLY (@Pharmaceuticals: Major) experienced а +11.28% price change this week, while OPHLY (@Pharmaceuticals: Major) price change was -5.91% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.80%. For the same industry, the average monthly price growth was -2.44%, and the average quarterly price growth was -1.35%.
GIKLY is expected to report earnings on Feb 27, 2025.
OPHLY is expected to report earnings on Jan 31, 2025.
The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
GIKLY | OPHLY | GIKLY / OPHLY | |
Capitalization | 8.79B | 9.03B | 97% |
EBITDA | 726M | 162B | 0% |
Gain YTD | -41.034 | -39.360 | 104% |
P/E Ratio | 75.19 | 11.40 | 659% |
Revenue | 6.46B | 447B | 1% |
Total Cash | 557M | 164B | 0% |
Total Debt | 10.9B | 9.17B | 119% |
GIKLY | OPHLY | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 83 | 55 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 19 Undervalued | 2 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 86 | 15 | |
PRICE GROWTH RATING 1..100 | 79 | 83 | |
P/E GROWTH RATING 1..100 | 97 | 76 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
OPHLY's Valuation (2) in the null industry is in the same range as GIKLY (19). This means that OPHLY’s stock grew similarly to GIKLY’s over the last 12 months.
OPHLY's Profit vs Risk Rating (100) in the null industry is in the same range as GIKLY (100). This means that OPHLY’s stock grew similarly to GIKLY’s over the last 12 months.
OPHLY's SMR Rating (15) in the null industry is significantly better than the same rating for GIKLY (86). This means that OPHLY’s stock grew significantly faster than GIKLY’s over the last 12 months.
GIKLY's Price Growth Rating (79) in the null industry is in the same range as OPHLY (83). This means that GIKLY’s stock grew similarly to OPHLY’s over the last 12 months.
OPHLY's P/E Growth Rating (76) in the null industry is in the same range as GIKLY (97). This means that OPHLY’s stock grew similarly to GIKLY’s over the last 12 months.
GIKLY | OPHLY | |
---|---|---|
RSI ODDS (%) | 2 days ago50% | 2 days ago66% |
Stochastic ODDS (%) | 2 days ago69% | 2 days ago61% |
Momentum ODDS (%) | 2 days ago58% | 2 days ago71% |
MACD ODDS (%) | 2 days ago54% | 2 days ago68% |
TrendWeek ODDS (%) | 2 days ago46% | 2 days ago61% |
TrendMonth ODDS (%) | 2 days ago59% | 2 days ago63% |
Advances ODDS (%) | 2 days ago70% | 16 days ago52% |
Declines ODDS (%) | 10 days ago71% | 2 days ago62% |
BollingerBands ODDS (%) | 2 days ago46% | 2 days ago57% |
Aroon ODDS (%) | 2 days ago55% | 2 days ago59% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GSXPX | 58.82 | N/A | N/A |
Goldman Sachs Small Cp Val Insghts P | |||
ACSMX | 11.35 | N/A | N/A |
Advisors Capital Small/Mid Cap | |||
LGMNX | 26.96 | -0.15 | -0.55% |
Loomis Sayles Global Allocation N | |||
FTEIX | 11.63 | -0.07 | -0.60% |
Fidelity Advisor Total Intl Equity I | |||
VSGIX | 82.89 | -0.85 | -1.02% |
Vanguard Small Cap Growth Index I |
A.I.dvisor indicates that over the last year, GIKLY has been closely correlated with GRFS. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if GIKLY jumps, then GRFS could also see price increases.
Ticker / NAME | Correlation To GIKLY | 1D Price Change % | ||
---|---|---|---|---|
GIKLY | 100% | +2.19% | ||
GRFS - GIKLY | 68% Closely correlated | +5.64% | ||
GIFOF - GIKLY | 27% Poorly correlated | N/A | ||
GIFLF - GIKLY | 25% Poorly correlated | N/A | ||
ORINY - GIKLY | 9% Poorly correlated | N/A | ||
OPHLY - GIKLY | 8% Poorly correlated | -1.41% | ||
More |
A.I.dvisor indicates that over the last year, OPHLY has been loosely correlated with OTSKY. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if OPHLY jumps, then OTSKY could also see price increases.
Ticker / NAME | Correlation To OPHLY | 1D Price Change % | ||
---|---|---|---|---|
OPHLY | 100% | -1.41% | ||
OTSKY - OPHLY | 42% Loosely correlated | -1.45% | ||
ALPMY - OPHLY | 36% Loosely correlated | -0.30% | ||
CHGCY - OPHLY | 26% Poorly correlated | +3.71% | ||
BAYRY - OPHLY | 22% Poorly correlated | -1.18% | ||
OPHLF - OPHLY | 14% Poorly correlated | N/A | ||
More |